Authors: Le Naour J; Centre de Recherche Des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France., Kroemer G; Centre de Recherche Des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Université de Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.; Institut du Cancer Paris CARPEM, Department of Biology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.

Source: Oncoimmunology [Oncoimmunology] 2023 Feb 17; Vol. 12 (1), pp. 2180237. Date of Electronic Publication: 2023 Feb 17 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neoplasms*, Ligands ; Adjuvants, Immunologic ; Membrane Proteins ; Neoplasm Proteins ; Toll-Like Receptors

Authors: Belovezhets T; Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia., Kulemzin S; Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia., Volkova O; Institute of Molecular and Cellular Biology of the SB RAS, 630090 Novosibirsk, Russia., Najakshin A; Institute of Molecular and Cellular Biology of the SB RAS, 630090 Novosibirsk, Russia., Taranin A; Institute of Molecular and Cellular Biology of the SB RAS, 630090 Novosibirsk, Russia., Gorchakov A; Almazov National Medical Research Centre, 197341 Saint Petersburg, Russia.

Source: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 12; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 12.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MeSH Terms: Antigens, CD20* , Immunotherapy, Adoptive*/methods, Animals ; Humans ; Mice ; Cytotoxicity, Immunologic ; T-Lymphocytes/immunology

Authors: Wang Y; State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China., Wang S; State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China., Wang H; State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China., Yang J; State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China., Zhou H; State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.

Source: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 07; Vol. 24 (4). Date of Electronic Publication: 2023 Feb 07.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Head and Neck Neoplasms*, Humans ; Squamous Cell Carcinoma of Head and Neck ; Receptors, Chemokine ; Tumor Microenvironment ; Chemokines

Authors: Iglesias-Escudero M; Immunology Division, LCMN, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, Badalona, Spain. miglesiase.germanstrias@gencat.cat.; Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. miglesiase.germanstrias@gencat.cat., Arias-González N; Immunology Division, LCMN, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, Badalona, Spain., Martínez-Cáceres E; Immunology Division, LCMN, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, Badalona, Spain. Emmartinez.germanstrias@gencat.cat.; Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. Emmartinez.germanstrias@gencat.cat.

Source: Molecular cancer [Mol Cancer] 2023 Feb 04; Vol. 22 (1), pp. 26. Date of Electronic Publication: 2023 Feb 04.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neoplasms*/pathology, Humans ; Immunity ; CD8-Positive T-Lymphocytes ; T-Lymphocytes, Regulatory ; Tumor Microenvironment

Authors: Melchor J; Department of Biochemistry and Genetics, Universidad de Navarra, Pamplona, Spain.; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Pamplona, Spain., Garcia-Lacarte M; Department of Biochemistry and Genetics, Universidad de Navarra, Pamplona, Spain.; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Grijalba SC; Department of Biochemistry and Genetics, Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Arnaiz-Leché A; Department of Biochemistry and Genetics, Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Pascual M; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Pamplona, Spain., Panizo C; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, Pamplona, Spain.; Current address: Department of Hematology and Hemotherapy, Hospital Universitario Donostia, San Sebastián, Spain., Blanco O; Department of Pathology, Universidad de Salamanca, Salamanca, Spain., Segura V; Bio-informatic Unit, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Current address: Data Intelligence Unit, Techedge Spain, Madrid, Spain., Novo FJ; Department of Biochemistry and Genetics, Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Valero JG; Department of Hematology-Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Pérez-Galán P; Department of Hematology-Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Martinez-Climent JA; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Roa S; Department of Biochemistry and Genetics, Universidad de Navarra, Pamplona, Spain sroa@unav.es.; Hemato-Oncology Program, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Feb; Vol. 11 (2).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Lymphoma, Large B-Cell, Diffuse*/drug therapy, Animals ; Mice ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Disease Models, Animal ; Proto-Oncogene Proteins c-bcl-2 ; Tumor Microenvironment

Authors: Labanieh L; Department of Bioengineering, Stanford University, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Mackall CL; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. cmackall@stanford.edu.; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.; Division of Blood and Marrow Transplantation and Cell Therapy, Department of Medicine, Stanford University, Stanford, CA, USA. cmackall@stanford.edu.

Source: Nature [Nature] 2023 Feb; Vol. 614 (7949), pp. 635-648. Date of Electronic Publication: 2023 Feb 22.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive*/adverse effects , Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/standards , Immunotherapy, Adoptive*/trends , T-Lymphocytes*/immunology , Receptors, Chimeric Antigen*, Humans ; Cell- and Tissue-Based Therapy/methods ; Cell- and Tissue-Based Therapy/trends ; Genetic Therapy/methods ; Genetic Therapy/trends ; Neoplasms/immunology ; Neoplasms/pathology ; Neoplasms/therapy ; Tumor Microenvironment ; B-Lymphocytes/pathology

Authors: Schaettler MO; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Desai R; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Wang AZ; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Livingstone AJ; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Kobayashi DK; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Coxon AT; Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA., Bowman-Kirigin JA; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Liu CJ; Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA., Li M; Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA., Bender DE; Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, St. Louis, Missouri, USA., White MJ; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA., Kranz DM; Biochemistry, University of Illinois Urbana-Champaign, Urbana, Illinois, USA., Johanns TM; Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Dunn GP; Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA gpdunn@mgh.harvard.edu.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Feb; Vol. 11 (2).

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Glioblastoma*, Mice ; Humans ; Animals ; Antigens, Neoplasm ; CD8-Positive T-Lymphocytes ; Receptors, Antigen, T-Cell

Authors: Bi J; The CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China haoyusun@ustc.edu.cn jc.bi@siat.ac.cn tzg@ustc.edu.cn., Huang C; The CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China., Jin X; The CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China., Zheng C; The CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China., Huang Y; The CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China., Zheng X; The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.; Institute of Immunology, University of Science and Technology of China, Hefei, People's Republic of China., Tian Z; The CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People's Republic of China haoyusun@ustc.edu.cn jc.bi@siat.ac.cn tzg@ustc.edu.cn.; The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.; Institute of Immunology, University of Science and Technology of China, Hefei, People's Republic of China.; Research Unit of NK Cell Study, Chinese Academy of Medical Sciences, Beijing, People's Republic of China., Sun H; The CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China haoyusun@ustc.edu.cn jc.bi@siat.ac.cn tzg@ustc.edu.cn.; Institute of Immunology, University of Science and Technology of China, Hefei, People's Republic of China.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Feb; Vol. 11 (2).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Intracellular Signaling Peptides and Proteins*/genetics , Intracellular Signaling Peptides and Proteins*/metabolism , Killer Cells, Natural*/metabolism , Neoplasms*/metabolism, Animals ; Humans ; Mice ; Tumor Microenvironment

Authors: Ciotti G; Onco Hematology, Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Marconi G; IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Sperotto A; Onco Hematology, Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Giannini MB; IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gottardi M; Onco Hematology, Department of Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Martinelli G; IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.

Source: Expert opinion on biological therapy [Expert Opin Biol Ther] 2023 Feb; Vol. 23 (2), pp. 175-194. Date of Electronic Publication: 2023 Feb 14.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE

MeSH Terms: Immunotherapy*/methods , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/pathology, Humans ; Aged ; Killer Cells, Natural ; T-Lymphocytes ; Tumor Microenvironment

Authors: Gotoh M; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan., Kurokawa T; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.; Clinical Research Center, Chiba University Hospital, Chiba, Japan., Yonekura S; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan., Okano M; Department of Otorhinolaryngology, International University of Health and Welfare, Chiba, Japan., Maekawa Y; Department of Medical Affairs, Torii Pharmaceutical Co., Ltd, Tokyo, Japan., Okamoto Y; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.; Chiba Rousai Hospital, Chiba, Japan., Okubo K; Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Source: Allergy [Allergy] 2023 Feb; Vol. 78 (2), pp. 563-568. Date of Electronic Publication: 2022 Sep 23.

Publication Type: Letter; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE

MeSH Terms: Sublingual Immunotherapy* , Cryptomeria* , Cupressus* , Rhinitis, Allergic*/therapy, Humans ; Pollen ; Tablets ; Allergens

Authors: Li Y; Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA., Flavell RR; Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA., Juarez R; Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA., Chow M; Department of Medicine, University of California, San Francisco, 1825 5(th) St, San Francisco, CA 94143, USA., Wu C; Department of Medicine, University of California, San Francisco, 1825 5(th) St, San Francisco, CA 94143, USA., Tsai K; Department of Medicine, University of California, San Francisco, 1825 5(th) St, San Francisco, CA 94143, USA., Daud A; Department of Medicine, University of California, San Francisco, 1825 5(th) St, San Francisco, CA 94143, USA., Behr SC; Department of Radiology and Biomedical Imaging, University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA. Electronic address: Spencer.behr@ucsf.edu.

Source: Clinical radiology [Clin Radiol] 2023 Feb; Vol. 78 (2), pp. e131-e136. Date of Electronic Publication: 2022 Nov 04.

Publication Type: Journal Article

Journal Info: Publisher: Blackwell Scientific Publications Ltd Country of Publication: England NLM ID: 1306016 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-229X (Electronic) Linking ISSN: 00099260 NLM ISO Abbreviation: Clin Radiol Subsets: MEDLINE

MeSH Terms: Immunotherapy*/adverse effects , Immunotherapy*/methods , Melanoma*/drug therapy , Melanoma*/pathology , Sarcoidosis*/diagnostic imaging , Sarcoidosis*/epidemiology , Sarcoidosis*/etiology, Humans ; Incidence ; Retrospective Studies

Authors: Xue K; Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China., Wang L; Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China., Liu J; Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.

Source: ChemMedChem [ChemMedChem] 2023 Feb 01; Vol. 18 (3), pp. e202200574. Date of Electronic Publication: 2022 Nov 29.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101259013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-7187 (Electronic) Linking ISSN: 18607179 NLM ISO Abbreviation: ChemMedChem Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neoplasms*/therapy, Humans ; Immunomodulation ; Immunity ; Bacteria

Authors: Zhang C; School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore., Xu M; School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore., He S; School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore., Huang J; School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore., Xu C; School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore., Pu K; School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, 70 Nanyang Drive, Singapore, 637457, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, 59 Nanyang Drive, Singapore, 636921, Singapore.

Source: Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2023 Feb; Vol. 35 (6), pp. e2208553. Date of Electronic Publication: 2022 Dec 18.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 9885358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-4095 (Electronic) Linking ISSN: 09359648 NLM ISO Abbreviation: Adv Mater Subsets: MEDLINE

MeSH Terms: Immunotherapy* , Neoplasms*/drug therapy, Humans ; Caspase 3 ; Macrophages/metabolism ; Immunosuppressive Agents/therapeutic use

Authors: Sun B; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China., Zhang J; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China., Li Z; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China., Xie M; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China., Luo C; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China., Wang Y; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China., Chen L; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China., Wang Y; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China., Jiang D; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China.; The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China.; Department of Microbiology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China., Yang K; Department of Immunology, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China.; The Key Laboratory of Bio-hazard Damage and Prevention Medicine, Basic Medicine School, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China.; Department of Rheumatology, Tangdu Hospital, Air-Force Medical University (the Fourth Military Medical University), Xi'an, Shaanxi, China.

Source: Frontiers in immunology [Front Immunol] 2023 Jan 31; Vol. 14, pp. 1075419. Date of Electronic Publication: 2023 Jan 31 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

MeSH Terms: Epitopes, T-Lymphocyte* , Immunotherapy*

Authors: Liu XZ; Institute of Rehabilitation Medicine, School of Rehabilitation Medicine, Binzhou Medical University, Yantai264003, PR China.; Shandong Laboratory of Advanced Materials and Green Manufacturing, Yantai264000, People's Republic of China., Wen ZJ; Binzhou Medical University Hospital, Binzhou256603PR China., Li YM; Institute of Rehabilitation Medicine, School of Rehabilitation Medicine, Binzhou Medical University, Yantai264003, PR China., Sun WR; Institute of Rehabilitation Medicine, School of Rehabilitation Medicine, Binzhou Medical University, Yantai264003, PR China., Hu XQ; Institute of Rehabilitation Medicine, School of Rehabilitation Medicine, Binzhou Medical University, Yantai264003, PR China., Zhu JZ; Institute of Rehabilitation Medicine, School of Rehabilitation Medicine, Binzhou Medical University, Yantai264003, PR China., Li XY; Institute of Rehabilitation Medicine, School of Rehabilitation Medicine, Binzhou Medical University, Yantai264003, PR China., Wang PY; Key Laboratory of Tumor Molecular Biology, Binzhou Medical University, Yantai264003, People's Republic of China., Pedraz JL; NanoBioCel Research Group, Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), 01006Vitoria-Gasteiz, Spain.; Networking Research Centre of Bioengineering, Biomaterials and Nanomedicine, Institute of Health Carlos III, 28029Madrid, Spain., Lee JH; Institute of Tissue Regeneration Engineering, Dankook University, Cheonan31116, Republic of Korea.; Department of Nanobiomedical Science, BK21 NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan31116, Republic of Korea.; Mechanobiology Dental Medicine Research Center, Dankook University, Cheonan31116, Republic of Korea., Kim HW; Institute of Tissue Regeneration Engineering, Dankook University, Cheonan31116, Republic of Korea.; Department of Nanobiomedical Science, BK21 NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan31116, Republic of Korea.; Mechanobiology Dental Medicine Research Center, Dankook University, Cheonan31116, Republic of Korea., Ramalingam M; Institute of Tissue Regeneration Engineering, Dankook University, Cheonan31116, Republic of Korea.; Department of Nanobiomedical Science, BK21 NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan31116, Republic of Korea.; Mechanobiology Dental Medicine Research Center, Dankook University, Cheonan31116, Republic of Korea.; School of Basic Medical Sciences, Chengdu University, Chengdu610106, People's Republic of China.; Department of Metallurgical and Materials Engineering, Atilim University, Ankara06830, Turkey., Xie S; Key Laboratory of Tumor Molecular Biology, Binzhou Medical University, Yantai264003, People's Republic of China., Wang R; Institute of Rehabilitation Medicine, School of Rehabilitation Medicine, Binzhou Medical University, Yantai264003, PR China.; Shandong Laboratory of Advanced Materials and Green Manufacturing, Yantai264000, People's Republic of China.

Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2023 Jan 25; Vol. 15 (3), pp. 3744-3759. Date of Electronic Publication: 2023 Jan 11.

Publication Type: Journal Article

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1944-8252 (Electronic) Linking ISSN: 19448244 NLM ISO Abbreviation: ACS Appl Mater Interfaces Subsets: MEDLINE

MeSH Terms: Immunotherapy*/methods , Multifunctional Nanoparticles*/therapeutic use , Neoplasms*/therapy , Bioengineering*, Humans ; Cell Line, Tumor ; Tumor Microenvironment/immunology ; Transport Vesicles/chemistry ; Transport Vesicles/immunology ; Bacterial Outer Membrane/chemistry ; Bacterial Outer Membrane/immunology ; Escherichia coli

Authors: Gao Y; State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergistic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China., Chen X; State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergistic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China., Wang B; State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergistic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China., Wang S; State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergistic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China., Wang J; State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergistic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China., Ren L; State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergistic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China., Jin WK; Department of Ultrasound, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China., Han H; Department of Ultrasound, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China., Wang L; State Key Laboratory for Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergistic Innovation Center for Advanced Materials (SICAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China.

Source: ACS applied bio materials [ACS Appl Bio Mater] 2023 Jan 16; Vol. 6 (1), pp. 257-266. Date of Electronic Publication: 2022 Dec 11.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: ACS Publications Country of Publication: United States NLM ID: 101729147 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2576-6422 (Electronic) Linking ISSN: 25766422 NLM ISO Abbreviation: ACS Appl Bio Mater Subsets: MEDLINE

MeSH Terms: Antibodies* , Immunotherapy*, Humans ; Animals ; Mice ; Neoplasm, Residual ; CD8-Positive T-Lymphocytes ; Magnetic Iron Oxide Nanoparticles ; Tumor Microenvironment

Authors: Tichet M; Swiss Institute for Experimental Cancer Research (ISREC), EPFL, Lausanne, Switzerland; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, 1011 Lausanne, Switzerland; Agora Translational Cancer Research Center, Rue du Bugnon 25A, 1011 Lausanne, Switzerland., Wullschleger S; Swiss Institute for Experimental Cancer Research (ISREC), EPFL, Lausanne, Switzerland; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland. Electronic address: stephanw987@gmail.com., Chryplewicz A; Swiss Institute for Experimental Cancer Research (ISREC), EPFL, Lausanne, Switzerland; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland; Agora Translational Cancer Research Center, Rue du Bugnon 25A, 1011 Lausanne, Switzerland., Fournier N; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Marcone R; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Kauzlaric A; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Homicsko K; Swiss Institute for Experimental Cancer Research (ISREC), EPFL, Lausanne, Switzerland; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland; Agora Translational Cancer Research Center, Rue du Bugnon 25A, 1011 Lausanne, Switzerland; Department of Oncology, CHUV, 46 Rue Bugnon, 1011 Lausanne, Switzerland; Center for Personalized Oncology, CHUV, 46 Rue Bugnon, 1011 Lausanne, Switzerland., Deak LC; Roche-Innovation Center Zurich, 8952 Schlieren, Switzerland., Umaña P; Roche-Innovation Center Zurich, 8952 Schlieren, Switzerland., Klein C; Roche-Innovation Center Zurich, 8952 Schlieren, Switzerland., Hanahan D; Swiss Institute for Experimental Cancer Research (ISREC), EPFL, Lausanne, Switzerland; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland; Ludwig Institute for Cancer Research, Lausanne Branch, 1011 Lausanne, Switzerland; Agora Translational Cancer Research Center, Rue du Bugnon 25A, 1011 Lausanne, Switzerland. Electronic address: douglas.hanahan@epfl.ch.

Source: Immunity [Immunity] 2023 Jan 10; Vol. 56 (1), pp. 162-179.e6.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

MeSH Terms: CD8-Positive T-Lymphocytes*/immunology , CD8-Positive T-Lymphocytes*/metabolism , Immunotherapy*/methods , Macrophages*/immunology , Macrophages*/metabolism , Neoplasms*/therapy, Animals ; Mice ; B7-H1 Antigen/immunology ; Disease Models, Animal ; Tumor Microenvironment ; Antibodies, Bispecific/immunology ; Interleukin-2 ; Programmed Cell Death 1 Receptor/immunology

Authors: Thomas S; Leibniz Institute for Immunotherapy, Div. Genetic Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Abken H; Leibniz Institute for Immunotherapy, Div. Genetic Immunotherapy, Regensburg, Germany.; Chair for Genetic Immunotherapy, University Regensburg, Regensburg, Germany.

Source: Frontiers in immunology [Front Immunol] 2023 Jan 09; Vol. 13, pp. 1090959. Date of Electronic Publication: 2023 Jan 09 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

MeSH Terms: Immunotherapy, Adoptive* , Receptors, Antigen, T-Cell* , Receptors, Chimeric Antigen*/genetics , Receptors, Chimeric Antigen*/metabolism, Cytokines/metabolism ; T-Lymphocytes ; Humans ; Leukemia/therapy ; Lymphoma/therapy

Authors: Wen J; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: jiachen.a.wen@outlook.com., Wang S; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China., Guo R; Institute for the Animal Health Industry of Yangzhou University, Wuxi Zodolabs Biotech Co. Ltd, Wuxi, 214000, China., Liu D; Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China. Electronic address: sammyld@163.com.

Source: European journal of medicinal chemistry [Eur J Med Chem] 2023 Jan 05; Vol. 245 (Pt 1), pp. 114884. Date of Electronic Publication: 2022 Oct 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

MeSH Terms: Antineoplastic Agents*/chemistry , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Immunotherapy*/methods , Neoplasms*/therapy , Receptor Protein-Tyrosine Kinases*/antagonists & inhibitors , Receptors, Granulocyte-Macrophage Colony-Stimulating Factor*/antagonists & inhibitors , Tyrosine Protein Kinase Inhibitors*/chemistry , Tyrosine Protein Kinase Inhibitors*/pharmacology , Tyrosine Protein Kinase Inhibitors*/therapeutic use, Humans ; Cytokines/metabolism ; Tumor Microenvironment/drug effects

Authors: Conde E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Casares N; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Mancheño U; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Elizalde E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Vercher E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Capozzi R; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Santamaria E; Hepatology Program, CIMA, University of Navarra, Pamplona, 31008 Navarra, Spain; CIBERehd, Instituto de Salud Carlos III, 28029 Madrid, Spain., Rodriguez-Madoz JR; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Hemat-Oncology Program, CIMA Universidad de Navarra, Pamplona, 31008 Navarra, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain., Prosper F; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Hemat-Oncology Program, CIMA Universidad de Navarra, Pamplona, 31008 Navarra, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain; Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, 31008 Navarra, Spain., Lasarte JJ; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Lozano T; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain. Electronic address: tlmoreda@unav.es., Hervas-Stubbs S; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; CIBERehd, Instituto de Salud Carlos III, 28029 Madrid, Spain. Electronic address: mshervas@unav.es.

Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Jan 04; Vol. 31 (1), pp. 48-65. Date of Electronic Publication: 2022 Aug 31.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

MeSH Terms: CD8-Positive T-Lymphocytes*/immunology , Forkhead Transcription Factors*/genetics , Forkhead Transcription Factors*/metabolism , Immunotherapy, Adoptive* , Melanoma*/therapy, Humans ; Glucose/metabolism ; Tumor Microenvironment